PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
11-Aug-2020 Genomenon’s Klein Named in “Top 25 Biotechnology CEOs of 2020” by TechCEOs Genomeon
10-Aug-2020 How COVID-19 changed the way patients responded to a heart attack University of Leeds
10-Aug-2020 Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID) Eli Lilly and Company
10-Aug-2020 BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China BioNTech SE
10-Aug-2020 CIMZIA® is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum UCB
10-Aug-2020 Lundbeck discontinues phase II proof of concept study of Lu AF11167 in patients with negative symptoms of schizophrenia H. Lundbeck A/S
10-Aug-2020 Fujifilm Selects Kinaxis RapidResponse for Agility in its Medical System Supply Chain Kinaxis Inc
10-Aug-2020 Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers Clovis Oncology, Inc
10-Aug-2020 Tiziana Life Sciences plc Announces Closing of $57.25 Million Offering Tiziana Life Sciences plc (
10-Aug-2020 Vifor Pharma Group reports continued growth in H1 2020 Vifor Pharma Group
10-Aug-2020 Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL Nordic Nanovector ASA
10-Aug-2020 CSL Behring to become latest partner in BaseLaunch Phase II CSL Behring
10-Aug-2020 BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020 BioNTech SE
10-Aug-2020 Novartis receives EC approval for new Xolair® indication to treat severe chronic rhinosinusitis with nasal polyps Novartis
10-Aug-2020 RedHill Biopharma’s Phase 2/3 COVID-19 Study Approved in Mexico RedHill Biopharma
10-Aug-2020 New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 Alliance for Regenerative Medicine
10-Aug-2020 New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 The Alliance for Regenerative Medicine
10-Aug-2020 AMRYT TO PRESENT AT VIRTUAL CANACCORD GENUITY 40TH ANNUAL GROWTH CONFERENCE Amryt
10-Aug-2020 Freeline update on IPO Syncona Limited
10-Aug-2020 Freeline Announces Pricing of Initial Public Offering Freeline Therapeutics Holdings plc